Canakinumab for treating periodic fever syndromes: TRAPS, HIDS/MKD and FMF (ages 2 years and older)

Document first published:
Page updated:
Topic:
Publication type:
,

NHS England will commission canakinumab for treating periodic fever syndromes: TRAPS HIDS/MKD and FMF in accordance with the criteria outlined in this document.

Document

Canakinumab for treating periodic fever syndromes TRAPS HIDS/MKD and FMF (ages 2 years and older)

Canakinumab for treating periodic fever syndromes TRAPS HIDS/MKD and FMF (ages 2 years and older)

  • PDF
  • 226 KB
  • 20 pages

Document

Clinical Panel Report

Clinical Panel Report

  • PDF
  • 201 KB
  • 2 pages

Document

Consultation Report

Consultation Report

  • PDF
  • 48 KB
  • 3 pages

Document

CPAG Summary Report

CPAG Summary Report

  • PDF
  • 94 KB
  • 10 pages

Document

Evidence Review

Evidence Review

  • PDF
  • 616 KB
  • 80 pages

Document

Stakeholder engagement report

Stakeholder engagement report

  • PDF
  • 45 KB
  • 3 pages